Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000874015-18-000039
Filing Date
2018-02-05
Accepted
2018-02-05 21:06:46
Documents
1
Period of Report
2018-02-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 6079
  Complete submission text file 0000874015-18-000039.txt   7386
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
LOSCALZO JOSEPH (Reporting) CIK: 0001276128 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-19125 | Film No.: 18576019